ArticleImmunotherapy2021
Immunity to glycan α-Gal and possibilities for the control of COVID-19.
José de la Fuente et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleImmunotherapy2021
José de la Fuente et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.